Christine Ha

Ms. Ha is the Chief Financial Officer of Ventus Therapeutics. She brings to Ventus more than 15 years of diverse strategic and financial experience within the healthcare sector.

Prior to Ventus, Christine was a Managing Director in the healthcare investment banking group at Morgan Stanley, where she advised biopharmaceutical companies on a broad range of strategic and financing initiatives. Previously, Christine held positions at Credit Suisse, Greenhill & Co, Aisling Capital, and HSBC. In her 13 years in investment banking, she executed over $24 billion of transactions, including M&A, collaborations, and financings.

Christine received an MBA with honors from The Wharton School at The University of Pennsylvania and a BA with honors in Statistics and a BS in Mathematics from The University of Chicago.